This topic contains a solution. Click here to go to the answer

Author Question: A patient who is scheduled for a bronchoscopy has arrived at the clinical facility. When preparing ... (Read 69 times)

nevelica

  • Hero Member
  • *****
  • Posts: 563
A patient who is scheduled for a bronchoscopy has arrived at the clinical facility. When preparing for the test, the patient reports feeling hungry and asks the nurse when he will be able to eat. What information should be provided by the nurse?
 
  A) You will not be allowed to eat or drink until the physician has seen you.
  B) You may immediately resume your normal diet after the test.
  C) You will not be able to eat or drink until your gag reflex has returned.
  D) It will be at least 8 hours after the procedure before you are allowed to eat or drink.

Question 2

A woman is diagnosed with senile dementia. The nurse should inform the family of the
 
  A) Possible need for home care
  B) Legal responsibility for the future
  C) Need for institutionalizatio n
  D) Lack of free resources of care



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Ans: C

Answer to Question 2

Ans: A





 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library